✦ LIBER ✦

26 Audit of gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancer in patients with EGFR mutation

✍ Scribed by Douglas, R.; Campbell, L.; McAleese, J.; Scullin, P.

Book ID: 122629240
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 43 KB
Volume: 79
Category: Article
ISSN: 0169-5002
DOI: 10.1016/S0169-5002(13)70026-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First-Line Gefitinib in Patients With Ad

First-Line Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer Harboring Somatic EGFR Mutations

✍ Sequist, L. V.; Martins, R. G.; Spigel, D.; Grunberg, S. M.; Spira, A.; Janne, P 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 228 KB

PCN110 Economic Evaluation of Gefitinib

PCN110 Economic Evaluation of Gefitinib for First-Line Treatment of EGFR Mutation Positive Advanced Non-Small Cell Lung Cancer Patients in Greece

✍ Fragoulakis, V.; Pallis, A.; Kourlaba, G.; Georgoulias, V.; Maniadakis, N. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Gefitinib as First-line Therapy for Adva

Gefitinib as First-line Therapy for Advanced or Metastatic Non-small Cell Lung Cancer Patients in Southern Taiwan

✍ Cheng-Ta Yang; Jen-Yu Hung; Chun-Liang Lai; Hsin-Chia Hung; Yung-Fa Lai; Meng-Ch 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 312 KB

NICE guidance on erlotinib for first-lin

NICE guidance on erlotinib for first-line treatment of EGFR-TK mutation-positive advanced or metastatic non-small-cell lung cancer

✍ Bernice Dillon; Bhash Naidoo; Helen Knight; Peter Clark 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 44 KB

Influence of first-line chemotherapy and

Influence of first-line chemotherapy and EGFR mutations on second-line gefitinib in advanced non-small cell lung cancer

✍ Wu, Jenn-Yu; Yu, Chong-Jen; Shih, Jin-Yuan; Yang, Chih-Hsin; Yang, Pan-Chyr 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 374 KB

A Pilot Trial of Gefitinib in Combinatio

A Pilot Trial of Gefitinib in Combination with Docetaxel in Patients with Locally Advanced or Metastatic Non–Small-Cell Lung Cancer

✍ Christian Manegold; Ulrich Gatzemeier; Erika Buchholz; Robert P. Smith; Abderrah 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 133 KB